Clinical Trials Directory

Trials / Conditions / Recurrent Solid Tumor

Recurrent Solid Tumor

7 registered clinical trials studyying Recurrent Solid Tumor — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069
Eli Lilly and CompanyPhase 1
Active Not RecruitingA Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479
Eli Lilly and CompanyPhase 1
RecruitingA Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer
NCT06184035
Spago Nanomedical ABPhase 1 / Phase 2
RecruitingStudy of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
NCT04901702
St. Jude Children's Research HospitalPhase 1 / Phase 2
CompletedA Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tum
NCT04474470
TyrNovo Ltd.Phase 1 / Phase 2
UnknownPhase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma
NCT03374007
Genor Biopharma Co., Ltd.Phase 1
TerminatedODSH + ICE Chemotherapy in Pediatric Solid Tumors
NCT02164097
New York Medical CollegePhase 1